from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3589/mutY

LFCtreatmentdescriptionclass of inhibitor

-0.402

Amikacinug/mL Amikacintranslation

-0.450

Cap5-10ug/mL Capreomycintranslation

-0.175

Rox10-50 ug/mL Roxithromycintranslation

0.970

SM2-5 ug/mL Streptomycintranslation

0.799

Tet5-10 ug/mL Tetracyclinetranslation

-0.691

Rif0.2-5ug/mL Rifampicintranscription

-0.189

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.648

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.464

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.344

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.785

Clofazimine10-13 ug/mL Clofaziminerespiration

0.042

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.560

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.847

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.008

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.049

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.357

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.144

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.418

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.892

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.629

KCN5-20 ug/mL Potassium cyaniderespiration

0.487

NaN30.2-2 mM Sodium aziderespiration

0.461

Nigericin50 uM Nigericinrespiration

-0.466

TRC10-150 ug/mL Triclosanrespiration

-1.586

TRZ10-25 ug/mL Thioridazinerespiration

0.017

Valinomycin0.5-10 uM Valinomycinrespiration

-0.067

ZnSO42 mM ZnSO4respiration

-0.250

menadione6-10 ug/mL Menadionerespiration

0.053

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.877

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.284

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.006

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.313

NRP_1Non-replicating persistence stage 1dosRassociated

0.974

Amp0.2mg/mL AmpicillincellWall

0.779

Cephalexin20-100 ug/mL CephalexincellWall

0.936

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.415

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.234

EMB10-20 ug/mL EthambutolcellWall

0.743

Eta12-40 ug/mL EthionamidecellWall

0.942

INH0.2-0.4 ug/mL IsoniazidcellWall

0.467

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.371

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.108

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.237

BZA0.12 mg/mL BenzamidearomaticAmides

-0.129

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.477

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.065

H2O24 mM hydrogen peroxideDNAdamaging

-0.111

Levo10 ug/mL LevofloxacinDNAdamaging

0.255

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.686

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.522

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.441

UVUV-irradiationDNAdamaging

-0.292

ARP41-4 ug/mL Antitubercular compound ARP4?

0.133

Antimycin12.5-50 ug/mL Antimycin A?

0.668

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.290

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.237

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.407

PA8240.2-2 ug/mL PA-824?

-0.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.295

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.108

Verapamil50 uM Verapamil?

0.429

mercaptoethanol2 mM 2-Mercaptoethanol?

1.267

methoxatin10-20 ug/mL Methoxatin?